In federal litigation in Minnesota, Rochester Drug Co-Operative Inc. sued Mylan and other pharmacy benefit managers, alleging a bribery and kickback scheme to favorably place, and increase the price of, the Epi-Pen to the exclusion of other competing epinephrine auto-injector brands, harming RDC by making it pay inflated prices for the Epi-Pen.
Depositions during discovery showed that movants Christopher Masseth and Joseph Brennan had day-to-day managerial responsibilities over the Epi-Pen and other autoinjector brands at RDC.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
